The Unitary Patent is a “wonderful tool” - Jean-Jacques Canonici, P&G

Managing IP is part of Legal Benchmarking Limited, 1-2 Paris Gardens, London, SE1 8ND

Copyright © Legal Benchmarking Limited and its affiliated companies 2026

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement

The Unitary Patent is a “wonderful tool” - Jean-Jacques Canonici, P&G

upc-web-icon.jpg

Jean-Jacques Canonici of Procter & Gamble urged patent owners to try the new Unitary Patent system, in an interview with Managing IP

Speaking at the Patent Reform Forum in Munich, Canonici said: “I hope it will be used because I fully believe it is a wonderful tool, but I have concerns about the costs.”

In particular, he said the level of renewal fees – which are now being discussed by participating member states – will be a key factor for many companies.

But he said that users bear a responsibility to try out the new system: “It would be a mistake to sit back and let others try the system. It is a joint responsibility to put some patents into the new system and that is how issues will get better resolution.”

See all the interviews from Munich on Managing IP’s YouTube channel. Note that all speakers are talking in a personal capacity, and their views are not necessarily those of their employers or clients.

more from across site and SHARED ros bottom lb

More from across our site

Richard de Bodo, who had a lengthy career at international firms, shares how he will address client needs and praises the unique offerings of smaller firms
An Australian top court decision clarifying honest concurrent use and wins by publishers against AI platforms were also among the top talking points
AIPPI has pulled the plug on its planned 2027 World Congress, and INTA has delayed hosting a meeting there, but the concerns won’t abate
Despite being outspent by a wealthy opponent, a trial attorney at King & Spalding says ‘relentless pursuit of the truth’ helped his team secure a $420m damages award for mobile gaming client
190 drugs face loss of exclusivity between 2026 and 2030, with the list including Bristol Myers Squibb’s blood-thinning drug Eliquis and immunotherapy medication Opdivo
Nokia, represented by a team from Bird & Bird, adjudged to have made fair offer to Asus and Acer in UK SEP dispute
Azhar Sadique and Kane Ridley, who founded the London office in 2023, are now both working in legal tech and AI-related roles, while another UK-based lawyer has also left
Partner Pierre Pérot rejoins the firm he left in 2022 alongside another returning lawyer, associate Camille Abba
Vaping dispute, in which Stobbs and Brandsmiths are the representatives, tested how the UK's Human Rights Act can apply to injunctions restraining unjustified threats
An AI platform being sold for £40m, and lateral hires involving law firms Womble Bond Dickinson and Cadwell Thomas were among the top talking points
Gift this article